Prof. Bing Xu received his BS and MS from Nanjing University in 1987 and 1990, Bing Xu obtained his PhD in 1996 from the University of Pennsylvania under the supervision of Timothy Swager. Before starting his independent research at the Hong Kong University of Science and Technology in August 2000, he was an NIH postdoctoral fellow with George Whitesides at Harvard University. Notably, Xu lab pioneered the integration of enzyme transformation (ET) and self-assembly (SA) for developing molecular biomaterials, synthesized the first dimeric nanoparticle consisting of quantum dot and nanomagnet for exploring nanoscience inside cells, reported the first case of using dopamine to anchor molecules on iron oxide surface, and demonstrated the first case of using enzymatic transformation and self-assembly to inhibit cancer cells selectively. Bing Xu has served as a reviewer for more than 100 journals. He was tenured as an associate professor in Jan 2006 and became a full professor in July 2008 at HKUST. Based on his works in HKUST and Brandeis, Bing Xu has been identified as "Highly-Cited Researchers in Chemistry" since 2014. He is currently a professor in the Department of Chemistry, Brandeis University. His research focuses on the applications of molecular engineering in materials, biology, and medicine.